Health Ministry drafts rules to help COVID-19 patients access new drugs

The draft New Drugs and Clinical Trials (Amendment) Rules stipulate manufacture and import of unapproved drugs based on a prescription by a hospital or medical institution

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2MASoTm
via IFTTT